Scp776 is the first therapy to show clinically meaningful efficacy in late-window stroke patients (treated up to 24 hours after onset) – a population with no approved drug options. Scp776 was safe and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback